High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology.

[1]  J. Prieto,et al.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology , 2000, Gut.

[2]  B. McMahon,et al.  Hepatitis B virions isolated with antibodies to the pre‐S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted , 2000, Transfusion.

[3]  M. Makuuchi,et al.  The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C , 2000, Cancer.

[4]  J. Pawlotsky,et al.  Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. , 2000, Journal of virological methods.

[5]  G. Colucci,et al.  Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection , 2000, Hepatology.

[6]  G. Raimondo,et al.  Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. , 1999, The New England journal of medicine.

[7]  Tomasz P. Michalak,et al.  Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis , 1999, Hepatology.

[8]  C. Trépo,et al.  [Hepatitis G virus in blood donors]. , 1999, Presse medicale.

[9]  E. Seifried,et al.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting , 1999, The Lancet.

[10]  F. Zoulim,et al.  Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance , 1999, Hepatology.

[11]  W. Gerlich,et al.  Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations , 1999, Journal of Clinical Microbiology.

[12]  L. Ferrell,et al.  Hepatitis after liver transplantation: the role of the known and unknown viruses. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  P. Gallian,et al.  Presence of TT virus in French blood donors and intravenous drug users. , 1998, Journal of hepatology.

[14]  R. Thomssen,et al.  Characterization of Unusual Escape Variants of Hepatitis B Virus Isolated from a Hepatitis B Surface Antigen-Negative Subject , 1998, Journal of Virology.

[15]  E. Stelzl,et al.  Quantitative Detection of Hepatitis B Virus DNA with a New PCR Assay , 1998, Clinical chemistry and laboratory medicine.

[16]  P. Simmonds,et al.  Detection of a novel DNA virus (TT virus) in blood donors and blood products , 1998, The Lancet.

[17]  C. Trépo,et al.  Analysis of a hepatitis delta virus isolate from the Central African Republic. , 1998, Research in virology.

[18]  T. Berg,et al.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.

[19]  T. Nishizawa,et al.  A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.

[20]  W. Carman,et al.  The clinical significance of surface antigen variants of hepatitis B virus , 1997, Journal of viral hepatitis.

[21]  Y. Kaneita,et al.  Hepatitis C virus is frequently coinfected with serum marker‐negative hepatitis B virus: Probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection , 1997, Journal of medical virology.

[22]  M. Loriot,et al.  Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. , 1997, Journal of hepatology.

[23]  N. Cuceanu,et al.  Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. , 1997, The Journal of general virology.

[24]  J. Stapleton,et al.  Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. , 1997, The Journal of infectious diseases.

[25]  P. Simmonds,et al.  Infection with hepatitis G virus among recipients of plasma products , 1996, The Lancet.

[26]  S. Pol,et al.  Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  P. Bedossa,et al.  An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.

[28]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[29]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[30]  A. Lok,et al.  Pathogenic role of hepatitis B virus in hepatitis B surface antigen—negative decompensated cirrhosis , 1995, Hepatology.

[31]  H. Schätzl,et al.  Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. , 1995, Journal of hepatology.

[32]  C. Bréchot,et al.  Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma , 1995, Hepatology.

[33]  R. Pennie,et al.  Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti‐HBc positive individuals, using the polymerase chain reaction , 1994, Journal of medical virology.

[34]  E. Tanaka,et al.  “Silent” Hepatitis B Virus Mutants Are Responsible for Non‐A, Non‐B, Non‐C, Non‐D, Non‐E Hepatitis , 1994, Microbiology and immunology.

[35]  C. Trépo,et al.  Identification of the third major genotype of hepatitis C virus in France. , 1994, Biochemical and biophysical research communications.

[36]  L. Ferrell,et al.  "Occult" hepatitis B virus as source of infection in liver transplant recipients , 1994, The Lancet.

[37]  J. Hoofnagle,et al.  Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B , 1993, Hepatology.

[38]  J. Sninsky,et al.  Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis , 1992, Transfusion.

[39]  J. Wands,et al.  Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection , 1991, Hepatology.

[40]  C. Trépo,et al.  Early and frequent detection of HBxAg and/or anti‐HBx in hepatitis B virus infection , 1990, Hepatology.

[41]  G. Gerken,et al.  Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. , 1990, The New England journal of medicine.

[42]  J. Hoofnagle.  Posttransfusion hepatitis B , 1990, Transfusion.

[43]  M. Loriot,et al.  Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. , 1990, Annals of internal medicine.

[44]  C. Bréchot,et al.  TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS , 1988, The Lancet.

[45]  J. Wands,et al.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. , 1985, The New England journal of medicine.

[46]  G. Keele.  Letter: Rubella vaccination. , 1973, Lancet.

[47]  A. Lok,et al.  Hepatitis B infection: pathogenesis and management. , 2000, Journal of hepatology.

[48]  T. Nishizawa,et al.  Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology , 1998 .